旅橙文化(08627.HK)預計年度淨虧損不超250萬元
格隆匯 3 月 8日丨旅橙文化(08627.HK)公佈,集團預期截至2020年12月31日止年度將錄得不超過人民幣250萬元的淨虧損,而截至2019年12月31日止年度則錄得純利約人民幣890萬元。
董事會認為,淨虧損主要由於與2019年同期相比,截至2020年12月31日止年度的收益大幅減少,此乃由於爆發疫情引致年內現有項目延遲或撤銷,以及新合約的需求及合約價值減少所致。隨着疫情爆發,多個省市採取的各種公共衞生應急政策(包括但不限於禁止人員在城市之間流動、頒佈強制隔離檢疫命令及要求臨時關閉商業及娛樂場所)對集團的業務造成影響,導致年內承接的項目數量減少,尤其是活動管理項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.